Cronos Group Inc.
TSX:CRON.TO · Toronto Stock Exchange
-$0.01 today
Vol 0.20M · Avg 0.19M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-0.9%
avg -0.1%
ROIC
-0.3%
avg -7.8%
ROA
-0.8%
avg -0.9%
Analysis
ROIC is currently the strongest return metric at -0.3% versus its period average of -7.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Michael Ryan Gorenstein | President, Chief Executive Officer & Chairman | $2.99M | — | 39 | — | — |
Anna Shlimak | Chief Financial Officer | $1.11M | — | 40 | — | — |
Jeffrey David Jacobson | Chief Growth Officer | $1.07M | — | 40 | — | — |
James Holm | Executive Officer | $974,509.00 | — | 42 | — | — |
Adam Wagner | General Manager of Cronos Israel | $891,670.00 | — | 43 | — | — |
Shannon Buggy | Senior Vice President & Global Head of People | $741,664.00 | — | 56 | — | — |
Arye Weigensberg | Senior Vice President and Head of Research & Development | — | — | 43 | — | — |
Harrison Aaron | Senior Director of Investor Relations & Corporate Development | — | — | — | — | — |
Jared Matthew Kenost | Principal Accounting Officer, Vice President & Controller | — | — | — | — | — |
Terry Gregory-Joseph Doucet | General Counsel & Corporate Secretary | — | — | 36 | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | +51.6% (14yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Forward estimates point to Revenue at +51.6% (14yr), giving you a quick read on expected growth from here.
Competitors
Peer companies in the same sector
Extendicare Inc.
TSX:EXE.TO
$3.20B
Trulieve Cannabis Corp.
TRUL.CN
$2.74B
Green Thumb Industries Inc.
GTII.CN
$2.49B
Sienna Senior Living Inc.
TSX:SIA.TO
$2.16B
WELL Health Technologies Corp.
TSX:WELL.TO
$1.12B
Knight Therapeutics Inc.
TSX:GUD.TO
$922.89M
Tilray Brands, Inc.
TSX:TLRY.TO
$794.17M
Verano Holdings Corp.
VRNO.NE
$593.56M
Cresco Labs Inc.
CL.CN
$403.82M
Rubicon Organics Inc.
ROMJ.V
$31.57M
Who manages CRON.TO?
Cronos Group Inc. (CRON.TO) lists 10 active executives. The top listed executive is Arye Weigensberg, Senior Vice President and Head of Research & Development.
Explore More
Continue the stock analysis
Jump to another research area for this company.